These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


111 related items for PubMed ID: 8740338

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Mechanisms and comparison of anti-allergic efficacy of topical lodoxamide and cromolyn sodium treatment in vernal keratoconjunctivitis.
    Avunduk AM, Avunduk MC, Kapicioglu Z, Akyol N, Tavli L.
    Ophthalmology; 2000 Jul; 107(7):1333-7. PubMed ID: 10890862
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of lodoxamide, disodium cromoglycate and fluorometholone on tear leukotriene levels in vernal keratoconjunctivitis.
    Akman A, Irkeç M, Orhan M.
    Eye (Lond); 1998 Jul; 12 ( Pt 2)():291-5. PubMed ID: 9683957
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy of lodoxamide 0.1% ophthalmic solution in resolving corneal epitheliopathy associated with vernal keratoconjunctivitis.
    Santos CI, Huang AJ, Abelson MB, Foster CS, Friedlaender M, McCulley JP.
    Am J Ophthalmol; 1994 Apr 15; 117(4):488-97. PubMed ID: 8154531
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy of lodoxamide eye drops on tear fluid cytology of patients with vernal conjunctivitis.
    Oguz H, Bitiren M, Aslan OS, Ozardali I.
    Acta Med Okayama; 1999 Jun 15; 53(3):123-6. PubMed ID: 10410789
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Lodoxamide for vernal keratoconjunctivitis.
    Med Lett Drugs Ther; 1994 Mar 18; 36(918):26. PubMed ID: 8121328
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A clinicopathological analysis of the efficacy of lodoxamide 0.1% eye drops on the conjunctiva of patients with vernal keratoconjunctivitis seen at Guinness Eye Centre, Lagos University Teaching Hospital.
    Adefule-Ositelu AO, Onakoya AO, Olasimbo OO, Adefule AK.
    Niger Postgrad Med J; 2006 Mar 18; 13(1):35-40. PubMed ID: 16633377
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacological mechanism of topical lodoxamide treatment in vernal keratoconjunctivitis: a flow-cytometric study.
    Avunduk AM, Avunduk MC, Dayanir V, Tekelioğlu Y, Dayioğlu YS.
    Ophthalmic Res; 1998 Mar 18; 30(1):37-43. PubMed ID: 9483586
    [Abstract] [Full Text] [Related]

  • 18. Contrast of the effect of alomide and sodium cromoglycate in the treatment of allergic eye diseases.
    Zhang W, Lin Z.
    Yan Ke Xue Bao; 2000 Sep 18; 16(3):214-6. PubMed ID: 12579651
    [Abstract] [Full Text] [Related]

  • 19. Lodoxamide versus spaglumic acid: a comparative double-blind trial on patients suffering from seasonal allergic conjunctivitis induced by Parietaria pollen.
    Purello D'Ambrosio F, Gangemi S, Ricciardi L, Cuzzocrea S, Di Lorenzo G.
    Allergol Immunopathol (Madr); 1997 Sep 18; 25(5):233-7. PubMed ID: 9395007
    [Abstract] [Full Text] [Related]

  • 20. [Evaluation of efficacy and safety of sterile solution of lodoxamide in patients with ocular allergy].
    Nicoară S.
    Oftalmologia; 2001 Sep 18; 52(2):81-4. PubMed ID: 11771108
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.